sequence-newborns-at-birth
Peter Diamandis recounted the dramatic cost reduction from the $3 billion Human Genome Project to the $100 genome today, driven by exponential technology. He advocated for universal sequencing at birth to identify medical vulnerabilities before symptoms appear, referencing his X Prize experience. The panel noted that metagenomics would become ubiquitous, enabling environmental DNA sweeps for biodiversity and disease surveillance. Alex added that mosaicism—multiple DNA copies in a single body—means we should sequence many cells per person, treating biology as a software engineering problem. Peter argued this could transform medicine from retrospective and reactive to proactive and personalized.
Genomic data reveals single nucleotide polymorphisms, structural variants, and pharmacogenomic markers that predict drug response and disease risk. Combining with AI analysis can flag actionable conditions in real time.
Peter was involved in the genomics race, funding a $1,000 genome X Prize that was canceled because the industry outpaced it.
Every child born should be sequenced. You learn so much at birth about what medical conditions that child when it's unable to communicate, during the first weeks and months of its life, to be able to make sure it has a smooth onboarding onto planet Earth.

